Healthcare >> CEO Interviews >> October 5, 2000
DAVID CHISWELL, BSc, PhD, is the Chief Executive Officer of Cambridge
Antibody Technology Group Plc. A founder of CAT, Dr. Chiswell has been
responsible for the operational management of CAT from its inception. He
joined the Board in December 1995 and took on the role of Chief
Executive Officer in 1996. Prior to CAT he spent nine years at Amersham
International Plc, where his main responsibilities included product
development and research management. Dr. Chiswell research experience
was gained at the MRC Institute of Virology in Glasgow, the Department
of Immunology and Microbiology at UCLA, California and in the Department
of Tumour Virology at the Imperial Cancer Research Fund in London. Profile
where you stand today?
Dr. Chiswell: Cambridge Antibody Technology was founded in 1990. We had
our London Stock Exchange
